Mark Holmes

Long-term efficacy and safety of alpha 1 proteinase inhibitor treatment for emphysema caused by severe alpha 1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

2017 | 1. lékařská fakulta

Publikace